BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6611348)

  • 1. 12-O-Tetradecanoylphorbol-13-acetate (TPA) directly inhibits spontaneous immunoglobulin secretion by in vivo antigen-induced human lymphoblastoid B cells.
    Brieva JA; Louie JS; Stevens RH
    J Clin Immunol; 1984 Jul; 4(4):280-6. PubMed ID: 6611348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 is essential for antibody secretion by human in vivo antigen-induced lymphoblastoid B cells.
    Brieva JA; Martin RA; Martinez-Maza O; Kagan J; Merrill J; Saxon A; Van Damme J; Stevens RH
    Cell Immunol; 1990 Oct; 130(2):303-10. PubMed ID: 2208301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis.
    Stevens RH; Benveniste E; Pineda E
    J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPA, tumor promoter-induced suppression of immunoglobulin secretion in human blood lymphocytes.
    Jagielski P; Gregg SL; Gajl-Peczalska KJ
    J Immunol; 1983 Mar; 130(3):1159-63. PubMed ID: 6600475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
    Kodo H; Gale RP; Saxon A
    J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells.
    Stevens R; Dichek D; Keld B; Heiner D
    J Clin Immunol; 1983 Jan; 3(1):65-9. PubMed ID: 6600745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phorbol ester (TPA) can replace macrophages in human lymphocyte cultures stimulated with a mitogen but not with an antigen.
    Koretzky GA; Daniele RP; Nowell PC
    J Immunol; 1982 Apr; 128(4):1776-80. PubMed ID: 6801122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells.
    Brieva JA; Targan S; Stevens RH
    J Immunol; 1984 Feb; 132(2):611-5. PubMed ID: 6228592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human antigen-induced lymphoblastoid B-cell function by an in vivo-induced suppressor T cell.
    Brieva JA; Stevens RH
    Cell Immunol; 1983 Apr; 77(1):109-19. PubMed ID: 6220813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human in vivo antigen-induced lymphoblastoid B cells are capable of cyclical antibody production in vitro.
    Brieva JA; Stevens RH
    J Immunol; 1984 Jul; 133(1):147-53. PubMed ID: 6609972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of human in vivo antigen-induced lymphoblastoid B cell precursors can be prevented by natural killer cells.
    Garcia-Alonso A; Brieva JA
    Clin Immunol Immunopathol; 1990 Oct; 57(1):163-71. PubMed ID: 2144222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes.
    Aman P; Gordon J; Klein G
    Immunology; 1984 Jan; 51(1):27-34. PubMed ID: 6606617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate.
    Ashman LK
    Cell Immunol; 1984 Sep; 87(2):613-25. PubMed ID: 6331899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of outgrowth of EB virus-transformed cells from normal human peripheral blood by a tumor promoter, TPA.
    Yamamoto H; Katsuki T; Harada S; Hinuma Y
    Int J Cancer; 1981 Feb; 27(2):161-6. PubMed ID: 6270011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phorbol ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells.
    Roth P; Halper JP; Weinstein IB; Pernis B
    J Immunol; 1982 Aug; 129(2):539-44. PubMed ID: 6979576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
    Harada S; Katsuki T; Yamamoto H; Hinuma Y
    Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of T lymphocytes by 12-O-tetradecanoylphorbol-13-acetate is resistant to inhibition by cyclosporin A.
    Kay JE; Meehan RT; Benzie CR
    Immunol Lett; 1983; 7(3):151-6. PubMed ID: 6607880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phorbol esters inhibit murine B cell differentiation to immunoglobulin secretion but not proliferation.
    Isakson PC; Simpson L
    J Immunol; 1984 Oct; 133(4):1788-91. PubMed ID: 6332133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS
    J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.